Evopoint Biosciences
China - BeijingBiotechnology
Focus: Evopoint Biosciences is a Beijing-based public biotech company specializing in next-generation antibody-drug conjugates (ADCs) and targeted protein degradation (TPD) drugs across oncology, infectious diseases, and metabolic indications. The company operates a diversified pipeline spanning early-to-late stage development with active programs in solid tumors, hematologic malignancies, and bacterial infections.
Profile data last refreshed 47m ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Evopoint Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Evopoint Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Evopoint Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
XNW4107
Bacterial InfectionsClinical Trials (1)
NCT04801043To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.
Phase 1Help build intelligence for Evopoint Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.